Cargando…
DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph
BACKGROUND: Recent advances in next-generation sequencing technologies have helped investigators generate massive amounts of cancer genomic data. A critical challenge in cancer genomics is identification of a few cancer driver genes whose mutations cause tumor growth. However, the majority of existi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281118/ https://www.ncbi.nlm.nih.gov/pubmed/35831792 http://dx.doi.org/10.1186/s12859-022-04788-7 |
_version_ | 1784746808247844864 |
---|---|
author | Wang, Chenye Shi, Junhan Cai, Jiansheng Zhang, Yusen Zheng, Xiaoqi Zhang, Naiqian |
author_facet | Wang, Chenye Shi, Junhan Cai, Jiansheng Zhang, Yusen Zheng, Xiaoqi Zhang, Naiqian |
author_sort | Wang, Chenye |
collection | PubMed |
description | BACKGROUND: Recent advances in next-generation sequencing technologies have helped investigators generate massive amounts of cancer genomic data. A critical challenge in cancer genomics is identification of a few cancer driver genes whose mutations cause tumor growth. However, the majority of existing computational approaches underuse the co-occurrence mutation information of the individuals, which are deemed to be important in tumorigenesis and tumor progression, resulting in high rate of false positive. RESULTS: To make full use of co-mutation information, we present a random walk algorithm referred to as DriverRWH on a weighted gene mutation hypergraph model, using somatic mutation data and molecular interaction network data to prioritize candidate driver genes. Applied to tumor samples of different cancer types from The Cancer Genome Atlas, DriverRWH shows significantly better performance than state-of-art prioritization methods in terms of the area under the curve scores and the cumulative number of known driver genes recovered in top-ranked candidate genes. Besides, DriverRWH discovers several potential drivers, which are enriched in cancer-related pathways. DriverRWH recovers approximately 50% known driver genes in the top 30 ranked candidate genes for more than half of the cancer types. In addition, DriverRWH is also highly robust to perturbations in the mutation data and gene functional network data. CONCLUSION: DriverRWH is effective among various cancer types in prioritizes cancer driver genes and provides considerable improvement over other tools with a better balance of precision and sensitivity. It can be a useful tool for detecting potential driver genes and facilitate targeted cancer therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04788-7. |
format | Online Article Text |
id | pubmed-9281118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92811182022-07-15 DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph Wang, Chenye Shi, Junhan Cai, Jiansheng Zhang, Yusen Zheng, Xiaoqi Zhang, Naiqian BMC Bioinformatics Research BACKGROUND: Recent advances in next-generation sequencing technologies have helped investigators generate massive amounts of cancer genomic data. A critical challenge in cancer genomics is identification of a few cancer driver genes whose mutations cause tumor growth. However, the majority of existing computational approaches underuse the co-occurrence mutation information of the individuals, which are deemed to be important in tumorigenesis and tumor progression, resulting in high rate of false positive. RESULTS: To make full use of co-mutation information, we present a random walk algorithm referred to as DriverRWH on a weighted gene mutation hypergraph model, using somatic mutation data and molecular interaction network data to prioritize candidate driver genes. Applied to tumor samples of different cancer types from The Cancer Genome Atlas, DriverRWH shows significantly better performance than state-of-art prioritization methods in terms of the area under the curve scores and the cumulative number of known driver genes recovered in top-ranked candidate genes. Besides, DriverRWH discovers several potential drivers, which are enriched in cancer-related pathways. DriverRWH recovers approximately 50% known driver genes in the top 30 ranked candidate genes for more than half of the cancer types. In addition, DriverRWH is also highly robust to perturbations in the mutation data and gene functional network data. CONCLUSION: DriverRWH is effective among various cancer types in prioritizes cancer driver genes and provides considerable improvement over other tools with a better balance of precision and sensitivity. It can be a useful tool for detecting potential driver genes and facilitate targeted cancer therapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-04788-7. BioMed Central 2022-07-13 /pmc/articles/PMC9281118/ /pubmed/35831792 http://dx.doi.org/10.1186/s12859-022-04788-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Chenye Shi, Junhan Cai, Jiansheng Zhang, Yusen Zheng, Xiaoqi Zhang, Naiqian DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title | DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title_full | DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title_fullStr | DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title_full_unstemmed | DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title_short | DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph |
title_sort | driverrwh: discovering cancer driver genes by random walk on a gene mutation hypergraph |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281118/ https://www.ncbi.nlm.nih.gov/pubmed/35831792 http://dx.doi.org/10.1186/s12859-022-04788-7 |
work_keys_str_mv | AT wangchenye driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph AT shijunhan driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph AT caijiansheng driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph AT zhangyusen driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph AT zhengxiaoqi driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph AT zhangnaiqian driverrwhdiscoveringcancerdrivergenesbyrandomwalkonagenemutationhypergraph |